These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1340156)

  • 1. Modulation of c-myc transcription by triple helix formation.
    Postel EH
    Ann N Y Acad Sci; 1992 Oct; 660():57-63. PubMed ID: 1340156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels.
    Postel EH; Flint SJ; Kessler DJ; Hogan ME
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8227-31. PubMed ID: 1896473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nuclear protein binding to two sites in the murine c-myc promoter by intermolecular triplex formation.
    Reddoch JF; Miller DM
    Biochemistry; 1995 Jun; 34(23):7659-67. PubMed ID: 7779812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
    Kim HG; Miller DM
    Biochemistry; 1995 Jun; 34(25):8165-71. PubMed ID: 7794930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex.
    Kim HG; Reddoch JF; Mayfield C; Ebbinghaus S; Vigneswaran N; Thomas S; Jones DE; Miller DM
    Biochemistry; 1998 Feb; 37(8):2299-304. PubMed ID: 9485376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
    Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
    Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triplex formation inhibits HER-2/neu transcription in vitro.
    Ebbinghaus SW; Gee JE; Rodu B; Mayfield CA; Sanders G; Miller DM
    J Clin Invest; 1993 Nov; 92(5):2433-9. PubMed ID: 7901237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element.
    Berberich SJ; Postel EH
    Oncogene; 1995 Jun; 10(12):2343-7. PubMed ID: 7784082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nuclease-hypersensitive element of the human c-myc promoter interacts with a transcription initiation factor.
    Postel EH; Mango SE; Flint SJ
    Mol Cell Biol; 1989 Nov; 9(11):5123-33. PubMed ID: 2601711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
    Kim HG; Miller DM
    Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-fos protooncogene transcription can be modulated by oligonucleotide-mediated formation of triplex structures in vitro.
    Lavrovsky Y; Stoltz RA; Vlassov VV; Abraham NG
    Eur J Biochem; 1996 Jun; 238(2):582-90. PubMed ID: 8681975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triplex forming ability of a c-myc promoter element predicts promoter strength.
    Firulli AB; Maibenco DC; Kinniburgh AJ
    Arch Biochem Biophys; 1994 Apr; 310(1):236-42. PubMed ID: 8161210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters.
    DesJardins E; Hay N
    Mol Cell Biol; 1993 Sep; 13(9):5710-24. PubMed ID: 8355712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gene expression by triple helix-directed DNA cross-linking at specific sites.
    Grigoriev M; Praseuth D; Guieysse AL; Robin P; Thuong NT; Hélène C; Harel-Bellan A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3501-5. PubMed ID: 8475098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide inhibition of IL2R alpha mRNA transcription by promoter region collinear triplex formation in lymphocytes.
    Orson FM; Thomas DW; McShan WM; Kessler DJ; Hogan ME
    Nucleic Acids Res; 1991 Jun; 19(12):3435-41. PubMed ID: 2062658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters.
    Snyder RC; Ray R; Blume S; Miller DM
    Biochemistry; 1991 Apr; 30(17):4290-7. PubMed ID: 1827033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional inhibition of the bacteriophage T7 early promoter region by oligonucleotide triple helix formation.
    Ross C; Samuel M; Broitman SL
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1674-80. PubMed ID: 1482373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.
    McGuffie EM; Catapano CV
    Nucleic Acids Res; 2002 Jun; 30(12):2701-9. PubMed ID: 12060688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro.
    Cooney M; Czernuszewicz G; Postel EH; Flint SJ; Hogan ME
    Science; 1988 Jul; 241(4864):456-9. PubMed ID: 3293213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF kappa B binding to interleukin-2 receptor alpha-regulatory sequence.
    Grigoriev M; Praseuth D; Robin P; Hemar A; Saison-Behmoaras T; Dautry-Varsat A; Thuong NT; Hélène C; Harel-Bellan A
    J Biol Chem; 1992 Feb; 267(5):3389-95. PubMed ID: 1737792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.